Business profile & competitive position
Equifax Inc. is classified under Industrials / Consulting Services, but its operations are best understood as a global data, analytics and technology company. According to its most recent 10-K, it supplies information solutions to businesses, governments and consumers, plus human-resources business-process automation and outsourcing services for employers. Its products are built on vast consumer and business databases spanning credit, employment, income, education, fraud and healthcare licensure data, and they are delivered through advanced analytics, artificial intelligence, machine learning and proprietary software tools. The company reports through three operating segments: Workforce Solutions, U.S. Information Solutions (USIS) and International.
The scale of its data assets is a central feature of the business. At December 31, 2025, The Work Number® held approximately 209 million active and 813 million total employment records. That kind of proprietary data archive is hard for new entrants to replicate quickly and supports recurring revenue relationships across mortgage, financial services, government, automotive, insurance, healthcare and telecommunications verticals. The largest client represented only about 3% of total revenue, pointing to a relatively diversified customer base rather than heavy dependence on a single buyer.
The financial returns back up the asset-light, data-driven narrative. Equifax’s ROE is 15.0%, while its net margin is 10.7%. A mid-teens ROE suggests the company earns above its cost of equity and converts its data assets into shareholder returns; the 10.7% net margin, while healthy, also leaves room for the reinvestment and cloud migration expenses management has emphasized.
Financial posture
Equifax’s current market capitalization is $17.1 billion and it trades at a trailing P/E of 25.3. At the current price of $145.145, that multiple implies the market is pricing in continued earnings power and some premium for the company’s data-analytics franchise. The earnings yield implied by the P/E is roughly 3.95%, which can be compared against risk-free rates when judging the stock’s relative valuation.
The company’s profitability metrics tell a consistent story. Net margin of 10.7% and ROE of 15.0% together indicate decent pricing power and capital efficiency. A beta of 1.30 means the stock has historically moved more than the overall market, so macro shocks or interest-rate swings tend to affect the shares disproportionately. The stock is currently below its 50-day EMA of $171.01 and the RSI is 23.2, indicating technically oversold conditions relative to its near-term price history.
Strategic priorities & outlook
Equifax’s most recent 10-K lays out four clear operational priorities. First, management wants to leverage Equifax Cloud capabilities to accelerate innovation, new product development and growth. Second, it aims to leverage and expand differentiated data assets and analytics, including through organic growth, acquisitions and partnerships. Third, the company is emphasizing a customer- and consumer-first culture focused on speed, flexibility, stability and performance. Fourth, it intends to execute strategic, accretive acquisitions that expand data capabilities and drive revenue growth.
Those priorities suggest Equifax is still in a “build and extend” phase: moving more workloads to its cloud infrastructure, layering new analytics and AI on top of existing data, and buying capabilities it cannot easily develop internally. The Work Number employment-record base is one example of a differentiated data asset that management is likely to keep monetizing through new products and partnerships. Revenue from international clients has been stable, accounting for 23% of total revenue in 2025, 24% in 2024 and 23% in 2023, so the strategy is not purely a U.S. growth story.
Macro & geopolitical exposure
Because Equifax sits in the consulting and information-services space, its revenue is tied to transaction and verification volumes across the economy rather than to the sale of physical goods. Regression in credit markets, mortgage originations, auto lending and employment screening would all reduce demand for its data products. Interest-rate cycles are therefore a first-order exposure: higher rates tend to dampen mortgage refinancing and new-loan activity, which in turn affects credit-reporting revenue.
Regulatory risk is another structural feature of the industry. Consumer-reporting and data-privacy rules—whether in the U.S., Europe or emerging markets—can affect what data Equifax is allowed to collect, how it stores data and how it prices products. Cybersecurity is also a material industry-wide concern given the sensitivity of the information involved. With roughly a quarter of revenue coming from outside the U.S., currency movements and cross-border data-transfer rules can move reported results. Finally, because management has named acquisitions as a strategic lever, antitrust and foreign-investment reviews could create execution risk for larger deals.
Recent developments
The most recent headlines have been concentrated around September 28, 2026. On that date, Zacks published “Why Equifax (EFX) is a Top Value Stock for the Long-Term,” and both GuruFocus and PR Newswire carried “Equifax Second Quarter 2026 Market Pulse Index Report Sees First Pause in K-Shaped Economic Widening in Three Years.” A few days earlier, on September 25, 2026, Zacks also ran “Why Equifax (EFX) is a Top Growth Stock for the Long-Term.” The Market Pulse report is notable because a pause in K-shaped widening would imply less divergence between higher- and lower-income consumer segments, a theme relevant to credit-risk products and employment-verification demand. Taken together, the headlines show a mix of equity-style framing—value versus growth—and macro commentary rather than company-specific operational news.
Earnings behavior & post-earnings drift
Equifax has an established history of beating earnings estimates. Over the last eight reported quarters, the beat rate is listed as 6/8 (100%), with an average earnings surprise of 3.9%. Across those same reports, the average 5-day price move after earnings has been 1% to the upside, classified as an “up” drift.
The most recent four quarters illustrate how “beat” does not always mean “rally immediately.”
- On July 21, 2026, Equifax reported EPS of $2.25 against a consensus estimate of $2.20, a 2.3% positive surprise. The stock fell 1.47% the next session but recovered to gain 8.1% over the following five trading days.
- On April 21, 2026, the company earned $1.86 versus a consensus of $1.69, a 10.1% beat. Despite the large upside, the stock sank 7.15% the next day and 10.76% over the following five days.
- On February 4, 2026, Equifax reported $2.09 versus $2.06, a 1.5% beat. The stock rose 5.51% the next day and 9.15% over the next five sessions.
- On October 21, 2025, the company earned $2.04 against an estimate of $1.94, a 5.2% beat. The stock barely moved the next day, up 0.31%, and drifted down 2.51% over the following five days.
The takeaway from this history is that Equifax has consistently delivered earnings above the official consensus, but the post-announcement price reaction has been noisy. Investors appear to react not just to the headline beat but also to guidance, forward commentary and the market’s real expectation heading into the print. The next scheduled report is October 20, 2026, before the market open, with a consensus EPS estimate of $2.22.
Frequently Asked Questions
What does Equifax actually do?
Equifax is a global data, analytics and technology company that provides information solutions to businesses, governments and consumers. It also offers human-resources business-process automation and employer outsourcing, with operations organized into Workforce Solutions, U.S. Information Solutions and International segments.
How has Equifax performed around recent earnings?
Over the last eight reported quarters, Equifax’s beat rate is cited as 6/8 (100%) with an average earnings surprise of 3.9% and an average 5-day post-earnings gain of 1%. In the last four quarters, however, the stock reaction has been mixed: two beats produced strong five-day gains, while the April 2026 and October 2025 beats were followed by notable weakness.
What are Equifax’s stated strategic priorities?
According to its most recent 10-K, Equifax is focused on leveraging its Equifax Cloud platform, expanding differentiated data assets and analytics through organic growth, acquisitions and partnerships, building a customer- and consumer-first culture, and completing accretive acquisitions that expand data capabilities.
For a deeper dive into how institutional analysts are interpreting these earnings trends, valuation metrics and strategic priorities, review the full institutional verdict and consensus breakdown.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-07-21 | $2.25 | $2.2 | +2.3% | -1.47% | +8.1% |
| 2026-04-21 | $1.86 | $1.69 | +10.1% | -7.15% | -10.76% |
| 2026-02-04 | $2.09 | $2.06 | +1.5% | +5.51% | +9.15% |
| 2025-10-21 | $2.04 | $1.94 | +5.2% | +0.31% | -2.51% |
| 2025-07-22 | $2 | $1.93 | +3.6% | - | - |
| 2025-04-22 | $1.53 | $1.41 | +8.5% | - | - |
Previous EFX editions
Get the institutional verdict on EFX
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the EFX verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.